Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases -- SCS Microinjector® Provides ...
Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting
A Replicable Growth Model: The Company’s joint venture strategy will serve as a scalable model for potential future partnerships, in an effort to enable Quipt to expand nationally while strengthening ...
Brainstorm To Announce Fourth Quarter And Fiscal Year 2024 Financial Results And Provide A Corporate Update
Call Scheduled for March 31, 2025, at 8:30 AM Eastern Time ...